Although tumor budding has been previously studied in esophageal carcinomas, little is known about its prognostic utility in superficial esophageal adenocarcinoma. An indication of its potential ...

Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas Two hundred fifty-one patients were identified, 107 with ...